-
2021-09-7
1d11bb86afc8014a2b4882bd84ca89466aad2347
/feed/2021/09/7/the-japanese-ministry-of-health-labour-and-welfare-signs-a-agreement-with-the-takeda-pharmaceutical-company-to-purchase
The Japanese Ministry of Health, Labour and Welfare signs a agreement with the Takeda Pharmaceutical Company to purchase 150 million doses of the Novavax COVID-19 vaccine that will be manufactured and distributed domestically by Takeda beginning next year.
1631120819
2021-09-7
b782c19401d5585b40e5ed5fb1f4ad7830858492
/feed/2021/09/7/the-japanese-ministry-of-health-labour-and-welfare-signs-a-agreement-with-takeda-pharmaceutical-company-to-purchase-150
The Japanese Ministry of Health, Labour and Welfare signs a agreement with Takeda Pharmaceutical Company to purchase 150 million doses of the Novavax COVID-19 vaccine that will be manufactured and distributed domestically by Takeda. The vaccine will be received from next year.
1631063210
2021-09-7
a8dda433025eb639f90180e3ebe7e84ee8441a66
https://cdn-japantimes.com/wp-content/uploads/2021/09/np_file_110931-870x489.jpeg
<98a6551605d8aed388de5681a525b8ce37799c71>https://cdn-japantimes.com/wp-content/uploads/2021/09/np_file_110931-870x489.jpeg98a6551605d8aed388de5681a525b8ce37799c71>
13
COVID-19 pandemic
1
/wiki/covid-19%20pandemic
Ministry of Health, Labour and Welfare
2
/wiki/ministry%20of%20health,%20labour%20and%20welfare
Novavax
37
/wiki/novavax%20covid-19%20vaccine
Takeda Pharmaceutical Company
14
/wiki/takeda%20pharmaceutical%20company
COVID-19 pandemic
Ministry of Health, Labour and Welfare
Novavax
Takeda Pharmaceutical Company
COVID-19 pandemic
2021-12-28
6dcf57d4ff72850f92b6df39f0792875cabae391
/feed/2021/12/28/the-ministry-of-health-and-family-welfare-issues-an-emergency-use-authorization-for-two-vaccines-namely-covovax-manufac
The Ministry of Health and Family Welfare issues an emergency use authorization for two vaccines, namely Covovax manufactured by the Serum Institute of India and Corbevax. The ministry also issues a similar authorization for the Merck & Co. anti-viral drug Molnupiravir.
1640739971
2021-12-28
7cd2dfbdbeb16d44b5b3054bca7e6eb31c119925
/feed/2021/12/28/the-ministry-of-health-and-family-welfare-issue-an-emergency-use-authorization-for-two-vaccines-namely-covovax-manufact
The Ministry of Health and Family Welfare issue an emergency use authorization for two vaccines, namely Covovax manufactured by the Serum Institute of India and Corbevax. The ministry also issues an similar authorization for Merck & Co. anti-viral drug Molnupiravir.
1640725584
2021-12-28
375c815d8705e6429fcba7a3adb5c551eb02b4fa
10
COVID-19 pandemic
Novavax
2
/feed/2021/12/28/the-ministry-of-health-and-family-welfare-issues-emergency-use-authorizations-for-the-covovax-vaccine-manufactured-by-th
The Ministry of Health and Family Welfare issues emergency use authorizations for the Covovax vaccine manufactured by the Serum Institute of India and the Corbevax vaccine. The ministry also issues an emergency use authorization for Merck & Co.'s anti-viral drug Molnupiravir.
2021-12-20
99aeee9cb70f6af204cd9c5614ca92be34c05518
/feed/2021/12/20/the-european-commission-authorizes-the-use-of-the-protein-based-novavax-covid-19-vaccine-after-the-european-medicines-ag
The European Commission authorizes the use of the protein-based Novavax COVID-19 vaccine after the European Medicines Agency recommends the use of the vaccine, becoming the fifth vaccine to be approved by the European Union.
1640048759
2021-12-20
1903d47a0b71f0cb7c7a5ac64b1716dfd0da61b4
30
COVID-19 pandemic
Novavax
2
/feed/2021/12/20/the-european-commission-authorizes-the-use-of-the-novavax-covid-19-vaccine-after-the-european-medicines-agency-recommend
The European Commission authorizes the use of the Novavax COVID-19 vaccine after the European Medicines Agency recommended the use of the vaccine, becoming the fifth vaccine to be approved for use by the European Union.
2021-11-17
cf65adee352940c84dbb126dc0cd75bfe75cad26
/feed/2021/11/17/the-food-and-drug-administration-of-the-philippines-approves-for-emergency-use-authorization-the-novavax-covid-19-vaccin
The Food and Drug Administration of the Philippines approves for emergency use authorization the Novavax COVID-19 vaccine and will be included in the national vaccination program.
1637183178
2021-11-17
563228d8e0d4e30f0ec543bab50c76e15b17b58b
23
COVID-19 pandemic
Novavax
2
/feed/2021/11/17/the-food-and-drug-administration-of-the-philippines-authorises-emergency-use-of-the-novavax-covid-19-vaccine-which-will
The Food and Drug Administration of the Philippines authorises emergency use of the Novavax COVID-19 vaccine, which will be included in the national vaccination program.
2021-11-1
b0c6f54e7a7f1f53fe268a0b7f1a582fe9c00493
10
COVID-19 pandemic
Novavax
2
/feed/2021/11/1/indonesia-becomes-the-first-country-in-the-world-to-approve-the-protein-based-novavax-covid-19-vaccine-which-will-be-ma
Indonesia becomes the first country in the world to approve the protein-based Novavax COVID-19 vaccine, which will be manufactured by the Serum Institute of India.
2021-09-28
963384c19f87cb316d76df630a95a62e63356115
/feed/2021/09/28/the-subject-expert-committee-of-central-drugs-standard-control-organisation-allows-serum-institute-of-india-to-conduct-t
The Subject Expert Committee of Central Drugs Standard Control Organisation allows Serum Institute of India to conduct trials of the Novavax COVID-19 vaccine for children aged 7 to 11 years old.
1632877571
2021-09-28
f056cca9e812c1f0ff2d473bf6f712716af1503a
13
COVID-19 pandemic
Novavax
2
/feed/2021/09/28/the-subject-expert-committee-of-the-central-drugs-standard-control-organisation-will-allow-the-serum-institute-of-india
The Subject Expert Committee of the Central Drugs Standard Control Organisation will allow the Serum Institute of India to conduct trials of the Novavax COVID-19 vaccine in children between the ages of 7 and 11 years.
2021-08-11
6e36ea1a36b91b58e0ef9e5841ba34c10e9e7c81
/feed/2021/08/11/denmark-confirms-that-they-will-purchase-280000-doses-of-the-novavax-covid-19-vaccine-for-a-total-price-of-37-million-c
Denmark confirms that they will purchase 280,000 doses of the Novavax COVID-19 vaccine for a total price of 37 million crowns ($5.84 million) or roughly $20.9 per dose as part of a European Union agreement with Novavax.
1628931976
2021-08-11
ae6e4a0c9d0a6783ace1fec7cd889b02c9bdccd0
/feed/2021/08/11/denmark-confirms-that-they-will-buy-280000-doses-of-the-novavax-covid-19-vaccine-for-a-total-price-of-37-million-crowns
Denmark confirms that they will buy 280,000 doses of the Novavax COVID-19 vaccine for a total price of 37 million crowns ($5.84 million) or roughly $20.9 per dose as part of a European Union agreement with the U.S. company.
1628730396
2021-08-11
1b9401a5ef504a4fd108614a1b8b5b434ffc0a39
40
COVID-19 pandemic
Novavax
2
/feed/2021/08/11/denmark-confirms-that-it-will-purchase-280000-doses-of-the-novavax-covid-19-vaccine-for-a-total-price-of-37-million-cro
Denmark confirms that it will purchase 280,000 doses of the Novavax COVID-19 vaccine for a total price of 37 million crowns ($5.84 million) or roughly $20.9 per dose as part of a European Union agreement with Novavax.
2021-08-4
c8a67aa0497b4cd2ef9bb0b7318178bf89189f0b
33
COVID-19 pandemic
Novavax
2
/feed/2021/08/4/the-european-commission-signs-an-agreement-with-novavax-to-purchase-200-million-doses-of-its-protein-based-covid-19-vacc
The European Commission signs an agreement with Novavax to purchase 200 million doses of its protein-based COVID-19 vaccines, including an option to purchase another 100 million doses through 2023.
2021-02-14
d251fad3fe24e216423da42765d144dc7781af09
/feed/2021/02/14/japan-s-ministry-of-health-officially-approves-pfizer-biontech-s-vaccine-which-is-the-first-government-approved-vaccine
Japan's Ministry of Health officially approves Pfizer-BioNTech's vaccine, which is the first government-approved vaccine in the country, three days after a government panel recommends the approval of the vaccine.
1613358634
2021-02-14
abfccbdc003deed591e15f310670e0d7336ce03e
/feed/2021/02/14/japan-s-ministry-of-health-officially-approves-pfizer-biontech-vaccine-which-is-the-first-government-approved-vaccine-i
Japan's Ministry of Health officially approves Pfizer-BioNTech vaccine, which is the first government-approved vaccine in the country, three days after a government panel recommends the approval of the vaccine.
1613329543
2021-02-14
54e250484ac4d3f18e7cc86e1b706a46482d7c3f
10
COVID-19 pandemic
Ministry of Health, Labour and Welfare
2
/feed/2021/02/14/japan-s-ministry-of-health-officially-approves-the-pfizer-biontech-vaccine-three-days-after-a-government-panel-recommen
Japan's Ministry of Health officially approves the Pfizer–BioNTech vaccine, three days after a government panel recommends its approval. This is the first government-approved vaccine in the country.
2021-01-28
c7c282c2868ec33b881c6a226926f5960f8182ef
57
COVID-19 pandemic
Novavax
2
/feed/2021/01/28/vaccine-developer-novavax-announces-that-their-vaccine-candidate-is-89-effective-in-preventing-severe-covid-19-based-o
Vaccine developer Novavax announces that their vaccine candidate is 89% effective in preventing severe COVID-19, based on trial data from the United Kingdom; their vaccine was less effective against new variants of the virus, based on data from South Africa.
2020-02-13
85adb38568808726c691a853fbcce524d4b79fea
/feed/2020/02/13/japan-s-ministry-of-health-labour-and-welfare-reports-the-country-s-first-death-related-to-the-covid-19-outbreak-a-wom
Japan's Ministry of Health, Labour and Welfare reports the country's first death related to the COVID-19 outbreak, a woman in her 80s.
1583969008
2020-02-13
5d8c59078a2877ac29a3208e66a36074a2dc79ad
/feed/2020/02/13/japan-s-health-ministry-reports-the-country-s-first-death-related-to-the-covid-19-outbreak-a-woman-in-her-80s
Japan's Health Ministry reports the country's first death related to the COVID-19 outbreak, a woman in her 80s.
1581843783
2020-02-13
3ba9e73c71d5eb22790c831522353b06c4f94962
11
COVID-19 pandemic
Ministry of Health, Labour and Welfare
2
/feed/2020/02/13/japan-s-ministry-of-health-labour-and-welfare-reports-the-country-s-first-death-related-to-the-covid-19-pandemic-a-wom
Japan's Ministry of Health, Labour and Welfare reports the country's first death related to the COVID-19 pandemic, a woman in her 80s.
/feed/2021/09/7/the-ministry-of-health-labour-and-welfare-signs-a-agreement-with-the-takeda-pharmaceutical-company-to-purchase-150-mill
The Japan Times
7
98a6551605d8aed388de5681a525b8ce37799c71
9
https://www.japantimes.co.jp/news/2021/09/07/national/japan-secures-150-million-novavax/
Japan secures 150 million Novavax vaccine doses
2021
Known as TAK-019 in Japan, the vaccine has proved to be 90% effective in preventing infections at clinical trials held abroad.
The Ministry of Health, Labour and Welfare signs a agreement with the Takeda Pharmaceutical Company to purchase 150 million doses of the Novavax COVID-19 vaccine that will be manufactured and distributed domestically by Takeda beginning next year.